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Abstract: -
Introduction 
 SLE is a systemic autoimmune disorder. One of the mechanisms by which
elimination of autoreactive lymphocytes takes place is apoptosis. Adefect in
apoptosis may thus contribute to the development of autoimmune disease. 
Patients and methods
The study included 34 Russian children patients with SLE in age between 
6-17 years old. Lymphocytes were isolated from venous blood by method of 
gradient centrifugation of all the blood through a Ficoll-pak solution. The 
quantity apoptotic cells was determined in leukocytes by flow cytometry Epics 
XL-2 (“Beckman Coulter”, USA). Analysis of lymphocyte subpopulations was 
carried by using two fluorescent labels: FITC conjugated monoclonal antibodies 
(CD-25 and CD-20) and phycoerythrin conjugated monoclonal antibody (CD-3,
CD-4 and CD-8).  
Results
After in vitro incubation in CO2 incubator for 36hr; the percentage of apoptotic lymphocytes from patients with 
SLE was significantly higher than from healthy donors (7.2* ± 4.7 % vs. 5.5 ± 3.2% respectively). This was found to be 
depending upon the SLE disease activity. Moreover, observed correlations between level apoptosis lymphocyte in SLE 
and the titer of antibodies to dsDNA (r = 0.5) and dosage prednisolone (r = 0.6). 
By analyzing lymphocyte phenotypes; there was no significant difference in percentage of CD3+T-cells from 
SLE compared to normal donors (62.4±7.2 vs. 68.7±9.9.); the same had been observed in CD8+ T-cells (20.9±5.5 vs. 
25.3±5.6); and in CD20+ B-cells (9.7±8.9 vs. 13.7±8.0). However, the percentage of CD4+T cell was significantly
decreased (P = 0,001) in patients with SLE compared to normal donors (25.5*±7.3 vs. 40.6±8.7). The immuno-
regulatory index was decreased in SLE compared to normal donors (1.2 vs 1.6 respectively). This phenotypes 
disbalance was associated with significant increased in the level of activated CD25+ lymphocytes in SLE compared to
normal healthy donors. 
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Systemic lupus erythematosus (SLE) is a 
systemic autoimmune disorder with a wide
spectrum of clinical and immunological 
abnormalities. The etiopathogensis of SLE is
unknown1.
SLE characterized by polyclonal 
activation of B lymphocytes and the production of 
a wide range of antibodies to nuclear and
cytoplasmic antigens. 
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The persistence of autoreactive B and T
lymphocytes is thought to be responsible for 
hypergamma-globulinaemia and autoantibody
production in SLE2,3.
 One of the mechanisms by which
elimination of autoreactive lymphocytes takes
place is programmed cell death (apoptosis) and a
defect in apoptosis may thus contribute to the 
development of autoimmune diseases4. A possible 
role of apoptotic cells in the pathogenesis of SLE 
has been suggested5. Moreover, it has been 
demonstrated that during the apoptotic process 
autoantigens are exposed at the outer surface of 
the apoptotic cell. This might allow the 
development of autoantibodies directed to 
intracellular localized antigens6.
Patients and methods
The characteristic of patients 
The study included 34 children patients 
with SLE in age between 6-17 years old.  The 
diagnosis and stages of SLE were established by 
criteria of American Rheumatism Association 
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based on clinical, immunological, and
instrumental methods of research.
Isolation of mononuclear and polymorph-onuclear
leukocytes from human peripheral blood 
Lymphocytes were isolated from venous 
blood by method of gradient centrifugation of all 
the blood through a Ficoll-pak solution (density
=1,077 g/ml). Granulocytes were received from
the fraction of cells settled at the bottom of the 
test-tube, of the centrifuged blood through Ficoll
gradient centrifugation. Granulocytes purified 
from erythrocytes by osmotic shock method in icy
water-bath. 
Determination quantity of apoptotic leukocytes 
The quantity apoptotic cells was 
determined  both in fresh intact peripheral blood 
leukocytes, and after incubation in RPMI-1640 
culture medium with addition of penicillin of 50  
I.U./ml; 50 mg /ml of streptomycin; 10 % PBS 
(pH 7,4) and 2m  glutamine in CO2 incubator at 
5 % CO2 for 36hr. 
Cells fixed in 70 % ethanol for 1 hr. at 
+4C0; then resuspended in 1 ml DNA-staining 
reagent (PBS, pH 7.4, containing 0.1 % of triton 
 -100. 0,1m EDTA (pH 7.4), 0.05 mg / ml
ribonuclease A, and 50 mg / ml propidium iodide)
for 1 hr. at room temperature. The stained cells
analyzed by flow cytometry Epics XL-2 
(“Beckman Coulter”, USA). Apoptotic nuclei 
were found out as wide peak of hypodiploid DNA
which were easily distinct from narrow diploid 
peak DNA of normal cells. 
Analysis of lymphocyte subsets 
The analysis of lymphocyte 
subpopulations carried out by flow cytometry -
the analyzer and the sorter of cells EPICS XL-2 
(“Beckman coulter”, USA). For excitation of 
fluorescence used the argon laser with a wave 
length excitation of 488 nm. Suspended 
lymphocytes incubated with monoclonal
antibodies from Sorbent company (Russia). We 
used two fluorescent labels: FITC (fluorescein 
isothiocyanate) conjugated monoclonal antibodies 
(CD-25 and CD-20) and phycoerythrin (a red 
luminescence) conjugated monoclonal antibody
(CD-3, CD-4 and CD-8). 
Determination quantity of apoptotic  -lymphocyte
subsets
1 x106 Cells   of the general lymphocyte 
subsets suspended in 50  l icy solution (PBS with
0.1 % sodium azide), then added on 2  l of the 
required FITC-conjugated monoclonal antibody
(anti-CD3, anti-CD-4, anti-CD-8, anti-CD-20), 
then incubate in darkness at +4 ° for 30 min. 
Cells fixed in 70 % ethanol and incubated at +4 °
for 1 hour; 0.1 ml propidium iodides added
followed by incubation incubate at room 
temperature for 1 hour. Analysis of apoptotic cells 
carried out by flow cytometer Epics XL-2 
(“Beckman Coulter”, USA). 
Results
Apoptosis of lymphocytes and granulocytes
The percentage apoptosis in freshly intact 
lymphocytes from patients with SLE and healthy
donors (1.6 ± 1. 5% vs. 1.1 ± 0.51% respectively)
are not significantly different (Fig.1).  
However, after incubation 36 hr  in 5 %
CO2 incubator; the percentage of apoptotic 
lymphocytes from patients with SLE was 
significantly higher than from healthy donors
(7.2* ± 4.7 % vs. 5.5 ± 3.2% respectively). On the 
other hand, percentages of apoptosis in 
granulocytes from patients with SLE and healthy
donors both in freshly intact (3.8 ± 3.1% vs. 3.6 ±
1.4% respectively), and after being cultured in 
culturing medium at 37C0 and 5 % C 2 (14.1 ±
8.4% vs. 15.3 ± 5.6% respectively) ; no
significant difference was reveal in level of 
apoptosis (Fig.1).  
Fig.1. Percentage apoptosis lymphocytes and
granulocytes freshly intact and after in vitro
incubation for 36hr, received from healthy donors
(a), and patients with SLE (b). 1 – Freshly
isolated lymphocytes, 2– lymphocytes after 36hr.
incubation, 3- Freshly isolated granulocytes, 4–
granulocytes after 36hr. incubation. 
Typical histogram of DNA distribution, 
freshly intact and after 18 hours incubation of 
lymphocytes and granulocytes fro m healthy
donors and patients with SLE, received by the 
flow cytometry method, is demonstrated in Fig. 2.
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Fig. 2. Histogram illustrated the distribution of
DNA lymphocytes. X-axis: the intensity of 
fluorescence; while Y-axis – the number of cells 
emitting fluorescence. Nuclei from non-apoptotic 
cells show a narrow peak with high fluorescence 
intensity, representing cells with normal
chromatin content (G0 or G1 phase of cell cycle),
hypodiploid - reflects quantity of apoptotic cells 
(A) i.e., nuclei of apoptotic cells stained in lower 
intensity by Propidium iodide, and can be
detected in a broad peak with lower fluorescence 
intensity. 
Apoptosis of lymphocytes and SLE disease activity
Depending upon the SLE disease activity, 
the level apoptosis of lymphocytes after in vitro
culturing was raised (Table 1). The third stage of 
SLE activity was characterized by the highest 
level of apoptosis in lymphocytes. However,
observed difference in the level apoptosis
granulocytes after in vitro culturing depending




















I (n=7) 1.5 ± 1.1 4.3 ± 1.5 3.01 ± 1.6 10.0 + 2.8
II (n=6) 1.5 ± 0.3 7.8* ± 2.0 2.72 ± 1.9 12.8 ±3.6
III (n=6) 1.1 ± 0.11 8.08* ± 1.0 2.03 ± 0.7 17.3 ± 6.8
*P< 0.05 compared to stage I activity.
Table 1. Dependence of the level apoptosis 
lympho-cytes and granulocytes upon the activity 
of SLE. The third stage of SLE disease activity 
characterized by the highest level of apoptosis in 
lymphocytes, while in granulocytes no significant 
difference observed with SLE disease activity.  
Apoptosis of lymphocyte subsets 
Moreover, level apoptosis was determined
in such lymphocyte subsets using flow cytometry
method. Our data shows that significant increased 
in percentage apoptosis in lymphocyte subsets 
CD4, CD8, and CD20 lymphocyte in patients with 
SLE compared to healthy donors; however, CD4
T cell in SLE underwent the much apoptosis than 
other lymphocyte subsets (Table 2).
% apoptotic lymphocytes of various  




CD3 CD4 CD8 CD20
Healthy
donors 






17.5*±8.6 24.3*±5.7 20.5*±8.5 17.4*±4.4
Table 2. Estimation apoptosis in various
lymphocyte subsets. CD4Tcells underwent much 
more apoptosis in SLE tha n other lymphocyte
subsets. 
 Apoptosis of lymphocytes and titer of antibodies to 
dsDNA 
The increased level apoptosis lymphocyte 
in SLE was found to be correlated with the titer of
antibodies to dsDNA after in vitro incubation for 
36 hours. The coefficient factor of the correlations 
was 0.5 (Fig. 3). 
Fig.3. Correlation between percentage apoptotic 
lymphocytes ‘after incubation in vitro for 36hr.’
and the titer antibodies to dsDNA (r = 0.50).  X 
axis- titers antibodies to dsDNA, Y axis – 
percentage apoptotic lymphocytes in patients 
with SLE after in vitro incubation for 36 hr. 
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Effect of prednisolone on apoptosis 
We analyzed level apoptosis in 
lymphocytes depending on a daily dosage 
prednisolone. The investigated patients with SLE
received prednisolone in a daily doze from 10 mg
to 40 mg. Observed correlation of dependence (r
= 0,6) between the level apoptosis in 
lymphocytes and dosage prednisolone (Fig.4), 
expressed by the linear equation of regression.
F Fig.4. The Dependence. (r = 0.6) of the level 
apoptosis in lymphocytes upon dosage 
prednisolone. X axis – Dosage prednisolone (10-
40mg), Y axis – percentage apoptotic
lymphocytes of patients with SLE after
incubation 36hr. (r = 0.6). 
Lymphocyte phenotypes in SLE 
Our results showed that, there was no
significant difference in percentage of CD3+T-
cells from SLE compared to normal donors
(62.4±7.2 vs. 68.7±9.9.); the same observation 
had been seen in CD8+ T-cells (20.9±5.5 vs. 
25.3±5.6); and in CD20+ B-cells (9.7±8.9 vs. 
13.7±8.0). However, the percentage of CD4+T cell
was significantly decreased (P = 0,001) in patients
with SLE compared to normal donors (25.5*±7.3
vs. 40.6±8.7) (Fig.5).  
Fig.5. Analysis of lymphocyte subpopulations in 
patients with SLE and healthy donors. X axis-
intensity of fluorescence, Y axis- number of cells. 
Histograms,  1. CD4 +T- cells from healthy
donors,    2. CD4+T- cells from patients with
SLE.  
The immuno-regulatory index (i.e. the 
ratio CD4/CD8) was decreased in SLE compared 
to normal donors (1.2 vs 1.6 respectively). (Fig.6).  
This phenotypes disbalance may be associated
with change in the level of activated lymphocytes
CD25+ (interleukin 2 receptor) cells, which was
found to be higher in SLE compared to normal 
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Fig.6. The immuno-regulatory index (CD4/CD8)
in patients with SLE compared to healthy donors
(1.2 vs. 1.6 respectively). 
Discussion
The absence of statistically significant
difference of lymphocytes underwent apoptosis, in 
freshly intact samples of peripheral blood of
investigated SLE patients compared to healthy
donors (fig.1), can be explained by that in peripheral 
blood apoptotic cells are quickly phagoctosed by
macrophages that do not allow registering this
phenomenon. Moreover, it was possible in this
phenomenon the inhibitory effect of soluble sFas in 
vivo. 
The significantly increased rate of apoptotic
SLE lymphocytes after in vitro culturing compared 
to healthy donors (7.2* ± 4.7 % vs. 5.5 ± 3.2%
respectively) (see fig.1) may reflect an increased rate
of in vivo apoptosis that reflects the in vivo 
activation of SLE peripheral T cells. Probably, 
apoptosis lymphocytes is a determining factor in the 
pathogenesis of SLE as distinguished from apoptosis
granulocytes which its increase is determined by
accompany inflammatory syndrome. This result is
matching with the same results reported by Elmen 
W. et al., J. Immunol. – 1994. 
Although the third stage of SLE activity was
characterized by the highest level of apoptosis in 
lymphocytes, no significant difference in apoptosis
granulocytes depending upon disease activity (table. 
1). Probably, apoptosis lymphocytes is a determining
factor in the pathogenesis of SLE as distinguished 
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from apoptosis granulocytes which its increase is 
determined by accompany inflammatory syndrome. 
This in contrary to work done by Courtney PA et al., 
(Ann Rheum Dis. – 1999) who reported increased 
apoptotic peripheral blood neutrophils in systemic 
lupus erythematosus: relations with disease activity, 
antibodies to double stranded DNA, and neutropenia 
The correlation of increased level 
apoptosis lymphocyte in SLE with the titer of 
antibodies to dsDNA after in vitro incubation for 
36 hours (fig 3) is very important, because 
apoptosis process is the multistage process 
determined by a many Factors. In other words, the 
increased level apoptosis lymphocyte in SLE may 
exceed capacity of phagocytic system which may 
result in uncompleted apoptosis and to release of 
various intracellular elements, such as apoptosis 
specific-DNA fragments, histone proteins… etc., 
which promotes formation autoantibodies. This 
increased apoptosis of lymphocytes in SLE 
patients can be considered as a source of 
autoantigens targeted by B-cells for formation of 
autoantibodies which is one of SLE disease 
manifestation. 
The observed correlation of dependence (r 
= 0,6) between the level apoptosis in lymphocytes 
and dosage prednisolone, expressed by the linear 
equation of regression (fig.4); may imply that  
apoptosis can be facilitated and initiated by the 
use of immunosuppressive medication7,8. 
Prednisolone may inhibit the entry of cells into 
G1 phase and arrest the progression of activated 
lymphocytes from the G1 to the S phase. This will 
promote apoptosis of cells and these findings 
confirm the data given in literatures 9,10.  
Since our results showed that increased 
apoptosis of lymphocytes after in vitro culturing, 
we therefore analyzed lymphocyte phenotypes in 
patients with SLE compared to normal healthy 
donors. The percentage of CD4+T cell was 
significantly decreased (P = 0,001) in patients 
with SLE compared to normal donors (25.5*±7.3 
vs. 40.6±8.7) (Fig.5). The immuno-regulatory 
index (i.e. the ratio CD4/CD8) was decreased in 
SLE compared to normal donors (1.2 vs 1.6 
respectively) (Fig.6).   
Conclusion 
As it is known that, the B-cell 
hyperactivity in SLE could depend on the cell 
activation, in particular, circulating CD4+ cells11 
i.e., CD4+T cells upon interaction with naïve B 
cells triggering its proliferation and antibody 
production. However, our study showed 
significantly decrease (P = 0,001) in percentage of 
CD4+T cell in patients with SLE compare to 
normal healthy donors (25.5*±7.3 vs. 40.6±8.7).  
This may be as a defense mechanism to protect 
certain organs from damage that may result from 
formation and deposition of immune complexes  
or may the etiology of SLE be as that of HIV 
infection. This is the breakthrough of our study 
which was the first time to be reported and 
registered in FEBS Special Meeting 2003 on 
Signal Transduction (3-8 July 2003., Belgium, 
Brussels). 
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